Suchergebnisse - "Carey, Ivana"

PubPharm (5)

1

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

enthalten in: Gastroenterology | 2024

von Sonneveld, M. | Chiu, S. | Park, J. | +26

2

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B : A multicentre cohort study

enthalten in: JHEP reports : innovation in hepatology | 2023

von Sonneveld, M. | Chiu, S. | Park, J. | +25

3

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

enthalten in: Journal of hepatology | 2022

von Sonneveld, M. | Chiu, S. | Park, J. | +24

CommentIn: J Hepatol. 2022 Oct;77(4):1223-1224. - PMID 35504443

4

Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels : A Multicenter Study (CREATE)

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Sonneveld, M. | Park, J. | Kaewdech, A. | +21

CommentIn: Clin Gastroenterol Hepatol. 2021 Dec;19(12):2680-2681. - PMID 33387671

5

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1

enthalten in: Journal of hepatology | 2020

von Spaan, M. | Carey, I. | Bruce, M. | +4

1
[1]